Company intelligence / Profile preview

Marrow

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Marrow is a biotechnology company focused on developing a new class of medicines that leverage the unique biological properties of the bone marrow. The company's platform aims to harness bone marrow-derived cells to create targeted therapies for a variety of high-need conditions, including autoimmune diseases and cancer. By treating the bone marrow as a central hub for the immune system, Marrow seeks to modulate immune responses and promote tissue regeneration. The company is currently in the pre-clinical stage, advancing its proprietary technology to identify and engineer specific cell populations for therapeutic use.

Therapeutic areas: OncologyImmunology
Modalities: Cell therapyStem cell therapy
Industry: Biotech

Beyond the preview

Go deeper on Marrow.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Marrow.

Explore the full profile